Yuval Geffen

2.5k total citations
86 papers, 1.5k citations indexed

About

Yuval Geffen is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Yuval Geffen has authored 86 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 24 papers in Infectious Diseases and 20 papers in Molecular Medicine. Recurrent topics in Yuval Geffen's work include Antibiotic Resistance in Bacteria (20 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antifungal resistance and susceptibility (10 papers). Yuval Geffen is often cited by papers focused on Antibiotic Resistance in Bacteria (20 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Antifungal resistance and susceptibility (10 papers). Yuval Geffen collaborates with scholars based in Israel, United States and Germany. Yuval Geffen's co-authors include Mical Paul, Khetam Hussein, Eugene Rosenberg, Ayelet Raz‐Pasteur, Ami Neuberger, Lea Bentur, Michal Gur, Shulamit Levenberg, Marianna Truman-Rosentsvit and Moran Bercovici and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Yuval Geffen

83 papers receiving 1.4k citations

Peers

Yuval Geffen
Kyeong Seob Shin South Korea
Kyoung Ho Roh South Korea
Hossein Salimnia United States
Rosemary C. She United States
Clare Ling United Kingdom
Christopher D. Doern United States
Kyeong Seob Shin South Korea
Yuval Geffen
Citations per year, relative to Yuval Geffen Yuval Geffen (= 1×) peers Kyeong Seob Shin

Countries citing papers authored by Yuval Geffen

Since Specialization
Citations

This map shows the geographic impact of Yuval Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuval Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuval Geffen more than expected).

Fields of papers citing papers by Yuval Geffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuval Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuval Geffen. The network helps show where Yuval Geffen may publish in the future.

Co-authorship network of co-authors of Yuval Geffen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuval Geffen. A scholar is included among the top collaborators of Yuval Geffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuval Geffen. Yuval Geffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Geffen, Yuval, et al.. (2025). ExoPTEN: Allogeneic Exosome Therapy for Spinal Cord Injury with Strong Therapeutic Potential and Clinical Promise. Cytotherapy. 27(5). S30–S31. 1 indexed citations
2.
Adler, Amos, et al.. (2025). Dissemination of a IncHI2A plasmid co-harboring the mcr-9 and blaNDM-1 genes in Israeli hospitals. Annals of Clinical Microbiology and Antimicrobials. 24(1). 45–45.
3.
Schechner, Vered, et al.. (2023). Identification and control of two outbreaks of unrelated New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli traced to the same endoscope defect. Infection Control and Hospital Epidemiology. 44(10). 1673–1675. 2 indexed citations
4.
Adler, Amos, Hiren Ghosh, Andrea M. Gross, et al.. (2023). Clinical and molecular features of NDM-producing Acinetobacter baumannii in a multicenter study in Israel. Annals of Clinical Microbiology and Antimicrobials. 22(1). 52–52. 5 indexed citations
5.
Hussein, Khetam, et al.. (2022). The Changing Epidemiology of Carbapenemase-Producing Enterobacterales. Rambam Maimonides Medical Journal. 13(1). e0004–e0004. 8 indexed citations
6.
Geffen, Yuval, et al.. (2021). The intraperitoneal bacteriology and antimicrobial resistance in acute appendicitis among children: a retrospective cohort study between the years 2007–2017. European Journal of Pediatrics. 180(7). 2091–2098. 3 indexed citations
8.
Yelin, Idan, Einat Shaer Tamar, Amir Argoetti, et al.. (2020). Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools. Clinical Infectious Diseases. 71(16). 2073–2078. 248 indexed citations
9.
Ben‐Zvi, Haim, et al.. (2020). Institutional Burden of Carbapenemase-Producing Enterobacterales: The Effect of Changes in Surveillance Culture Methodology. Microbial Drug Resistance. 26(11). 1350–1356. 3 indexed citations
10.
Cohen, Regev, Talya Finn, Svetlana Paikin, et al.. (2019). Disseminated “Haemophilus quentini” infection in a patient with multiple myeloma — a case report and review of the literature. Diagnostic Microbiology and Infectious Disease. 94(3). 293–296. 3 indexed citations
11.
Petersiel, Neta, Roni Bitterman, Yuval Geffen, et al.. (2019). β-lactam antibiotics vs. vancomycin for the early treatment of enterococcal bacteraemia: A retrospective cohort study. International Journal of Antimicrobial Agents. 53(6). 761–766. 4 indexed citations
12.
Korem, Maya, Yuval Geffen, & Sharon Amit. (2019). Don’t mess with the machine — evaluation of fluconazole susceptibility testing for Candida glabrata using the new VITEK2 AST-YS08 card following species modification. Diagnostic Microbiology and Infectious Disease. 96(2). 114896–114896. 5 indexed citations
13.
Gorelik, Yuri, Mical Paul, Yuval Geffen, & Mogher Khamaisi. (2017). Urinary Tract Infections Due to Nontyphoidal Salmonella. The American Journal of the Medical Sciences. 353(6). 529–532. 8 indexed citations
15.
Bitterman, Roni, et al.. (2016). Morphological changes induced by β-lactam antibiotics observed on Gram staining. Clinical Microbiology and Infection. 23(1). 26–26. 4 indexed citations
16.
Lerner, A., Ester Solter, Amos Adler, et al.. (2015). Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel. European Journal of Clinical Microbiology & Infectious Diseases. 35(1). 149–154. 38 indexed citations
17.
Dickstein, Yaakov, Yuval Geffen, Leonard Leibovici, & Mical Paul. (2015). Comparison of Antibiotic Susceptibility Patterns of Bacterial Isolates Based on Time From Hospitalization and Culture Source: Implications for Hospital Antibiograms. Infection Control and Hospital Epidemiology. 37(2). 212–214. 2 indexed citations
18.
Braun, Eyal, Khetam Hussein, Yuval Geffen, et al.. (2014). Predominance of Gram-negative bacilli among patients with catheter-related bloodstream infections. Clinical Microbiology and Infection. 20(10). O627–O629. 40 indexed citations
19.
Adler, Amos, Marc V. Assous, Yuval Geffen, et al.. (2014). A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel. Clinical Microbiology and Infection. 21(3). 230–235. 18 indexed citations
20.
Bitterman, Roni, Ilana Oren, Yuval Geffen, et al.. (2012). Prolonged Fever and Splinter Hemorrhages in an Immunocompetent Traveler With Disseminated Histoplasmosis. Journal of Travel Medicine. 20(1). 57–59. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026